A new research paper describes a stepped-care treatment to help improve the quality of life for patients with chronic uticaria.
Hydroxychloroquine May Reduce Risk of Congenital Heart Block
A recent study finds hydroxychloroquine shows promise in secondary prevention of congenital heart block for pregnant women with autoimmune disease. Maternal-fetal medicine specialist Jeff Chapa, MD, and pediatric cardiologist Peter Aziz, MD, explain.
Rheumatology, Immunology and COVID-19: The Cytokine Storm and Open Trials
As the medical community struggles to understand and limit the impact of the rapidly evolving COVID-19 pandemic, there are still more questions than answers. In this article, rheumatologists discuss the cytokine storm and experimental therapies, including IL-6 inhibitors and hydroxychloroquine.
Novel Image Analysis Platform May Detect Early Signs of Retinal Toxicity Secondary to Hydroxychloroquine Use
Ellipsoid zone mapping, a new image visualization/analysis platform on optical coherence tomography, may be an effective screening tool to identify subtle retinal changes indicative of toxicity from hydroxychloroquine treatment, Cleveland Clinic research indicates.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Study Finds Room for Improvement When Screening Patients for Ophthalmic Side Effects of Hydroxychloroquine
Risk of blindness is a side effect of hydroxychloroquine, a common drug for RA and lupus, but rates of adequate screening for toxicity could be improved.